Harrow Health: Mostly Good, Some Bad

12:20pm, Monday, 12'th Jun 2023
Harrow Healthcare is well-positioned to grow in the US Ophthalmology market, with a branded pharma sales strategy that could boost growth and margins. The company's medium-term earnings outlook is str
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like MicroStrategy (MSTR), SPX Technologies (SPXC), Cvent (CVT), Harrow Health (HROW) and Banco (BM
Harrow had a $6.6 million loss in the first quarter. It just launched its latest therapy, the ocular anesthesia Iheeza.
Harrow Health, Inc. (NASDAQ:HROW ) Q1 2023 Earnings Conference Call May 11, 2023 4:45 PM ET Company Participants Jamie Webb - Director, Communications and IR Mark Baum - Chief Executive Officer Andrew
Harrow Health (HROW) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to earnings of $0.03 per share a year ago.
Harrow Health's (HROW) first-quarter top line is likely to have been driven by its recent product launches.
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are META, CMG, ACLX, HROW and PRG.
Harrow (HROW) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our sho

Bull Of The Day: Harrow Health (HROW)

08:24am, Monday, 24'th Apr 2023
This "roll up" play is expected to post some good growth this year as well as next.
We have narrowed our search to five stocks that have provided more than 50% returns year to date with more upside left. These are: CRD.A, REPX, UVE, ASUR and HROW.
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are TGLS, CRD.B, REPX, HROW and LNTH.
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are BLPH, CRD.B, REPX, HROW and LNTH.
Harrow (HROW) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Harrow Health, Inc. (NASDAQ:HROW ) Q4 2022 Earnings Conference Call March 23, 2023 4:45 PM ET Company Participants Jamie Webb - Director, Communications and IR Mark Baum - Chief Executive Officer Andr

Buy Harrow Health: Correcting A Shortsighted View

10:42am, Thursday, 23'rd Feb 2023
Harrow entered an opaque market filled with middle men and dissatisfied ophthalmologists. Harrow understands their customers, solves their pain points, and has earned their trust. This is a deep moat.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE